poisar

Stocks · News reference

Salesforce To Report Mixed Q2; Investors Remain Skeptical About H2 Acceleration

BenzingaPriya Nigam

Salesforce Q2 has analysts expecting mixed results. One expert maintains a Buy rating, citing positive signs in core growth drivers.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Salesforce, Inc. (CRM)

    Filed: 2026-09-04 AccNo: 0001108524-26-000197 Size: 149 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers